INMODE Aktie

>INMODE Aktienkurs

12.8225 EUR (Tradegate)

Ask: 12.885 EUR / 463 Stück

Bid: 12.76 EUR / 468 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

INMODE Aktie über LYNX handeln

Intraday

1 Jahr

>INMODE Performance

1 Woche: +3,9%

1 Monat: -0,6%

3 Monate: -10,2%

6 Monate: -21,6%

1 Jahr: -21,4%

laufendes Jahr: -20,5%

>INMODE Aktie

Name:

INMODE LTD IS -,01

Land:

Israel

Sektor:

Gesundheit

ISIN/ Wkn:

IL0011595993 / A2PP3A

Symbol/ Ticker:

154 (Frankfurt) / INMD (NASDAQ)

Kürzel:

FRA:154, ETR:154, 154:GR, NASDAQ:INMD

Index:

Webseite:

https://www.inmodemd.com/

Marktkapitalisierung:

743.73 Mio. EUR

Umsatz:

339.77 Mio. EUR

EBITDA:

95.93 Mio. EUR

Gewinn je Aktie:

1.68 EUR

Schulden:

4.84 Mio. EUR

Liquide Mittel:

444.12 Mio. EUR

Umsatz-/ Gewinnwachstum:

-3% / -23.2%

KGV/ KGV lG:

6.28 / 8.38

KUV/ KBV/ PEG:

2.73 / 1.38 / 2.73

Gewinnm./ Eigenkapitalr.:

44.79% / 24.5%

Dividende je Aktie:

Dividendenrendite/ -schätzung:

- / -

Insiderhandel:

Suchwörter:

INMODE

Letzte Datenerhebung:

05.07.25

>INMODE Eigentümer

Aktien: 60.92 Mio. St.

f.h. Aktien: 58.18 Mio. St.

Insider Eigner: 15.35%

Instit. Eigner: 72.44%

Leerverk. Aktien: 7.8%

>INMODE Peer Group

CHECK-CAP

COLLPLANT

ENLIVEX

ENTERA BIO

GALMED

MEDIWOUND

NEUROSENSE

SOL-GEL

UROGEN PHARMA

>INMODE Chart & Kurs - NASDAQ

>INMODE News

28.05.25 - 14:33	InMode Response Letter to DOMA by Moshe Mizrahy, CEO, Dated May 28, 2025 (PR Newswire)
	YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capital Management LLC ("DOMA") CEO and CIO Pedro Escudero in response to issues presented in his public......

23.05.25 - 18:15	Do Options Traders Know Something About InMode Stock We Don′t? (Zacks)
	Investors need to pay close attention to InMode stock based on the movements in the options market lately....

20.05.25 - 15:18	InMode Announces Health Canada Certification of the IgniteRF Platform with the New QuantumRF Technology (PR Newswire)
	YOKNEAM, Israel, May 20, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to announce Health Canada certification of IgniteRF, an advanced platform offering a comprehensive suite of minimally invasive radiofrequency......

09.05.25 - 14:24	DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program (PR Newswire)
	Believes the Board Should Immediately Resume and Accelerate Buybacks Asserts Board Should Remove Moshe Mizrahy as CEO of the Company MIAMI, May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a significant stockholder of InMode Ltd. (NYSE: INMD) ("InMode"), today sent a......

07.05.25 - 14:31	InMode to Present at Upcoming Investor Conferences and Events (PR Newswire)
	YOKNEAM, Israel, May 7, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences: BNP 3rd Annual Aesthetics Day Presenters: Moshe Mizrahy, Chief Executive Officer......

06.05.25 - 16:45	InMode wins case against DHGate sellers over counterfeit products (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.25 - 14:06	InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges (PR Newswire)
	IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of California granted InMode's motion for default judgment against the DHGate sellers and......

28.04.25 - 20:06	InMode slides on lowered full year profit guidance (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

28.04.25 - 19:54	Pressmaster DMCC: Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York City (Newsfile)
	New York, New York--(Newsfile Corp. - April 28, 2025) - Eyes On Park, a leading optometry practice in Gramercy Park, announces the introduction of the cutting-edge Envision by InMode system for co......

28.04.25 - 16:00	InMode (INMD) Lags Q1 Earnings Estimates (Zacks)
	InMode (INMD) delivered earnings and revenue surprises of -6.06% and 0.61%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?...

28.04.25 - 13:06	InMode Non-GAAP EPS of $0.31 misses by $0.04, revenue of $77.88M beats by $0.31M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

28.04.25 - 13:03	InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year Decrease (PR Newswire)
	In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the......

25.04.25 - 16:42	InMode Q1 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.04.25 - 17:30	Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline (Zacks)
	InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

14.04.25 - 13:21	InMode expects Q1 sales below estimates (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.04.25 - 13:01	InMode to Report First Quarter 2025 Financial Results and Hold Conference Call on April 28, 2025, Expects Q1 Revenue Between $77.2M-$77.5M, Reiterates FY 2025 Revenue Guidance Between $395M-$405M (PR Newswire)
	Conference call to be held on Monday, April 28, 2025, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 14, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for......

10.04.25 - 19:00	InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock? (Zacks)
	InMode (INMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term....

26.03.25 - 13:33	InMode to Present at the 24th Annual Needham Virtual Healthcare Conference (PR Newswire)
	YOKNEAM, Israel, March 26, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer, and Yair Malca, Chief Financial Officer, will present at the 24th Annual Needham Virtual......

25.03.25 - 16:30	Is InMode (INMD) Stock Undervalued Right Now? (Zacks)
	Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks....

06.03.25 - 14:12	InMode CEO responds to DOMA Perpetual’s demands (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram